title: The next 10 years in antihypertensive treatment. Interview by Tanya Stezhka.
abstract: Interview by Tanya Stezhka Dr Cooper-DeHoff is an Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, at the University of Florida (FL, USA). Her principle research focuses on hypertension, diabetes and the metabolic syndrome. She was a principle investigator of the INVEST study, which evaluated hypertension treatments in older coronary artery disease patients, and is currently a coinvestigator on two NIH grants evaluating pharmacogenetic hypertension associations. She is a member of the American Heart Association, American Society of Hypertension, American College of Cardiology and Florida Society of Hospital Pharmacists.
authors.forename: Rhonda M
authors.initials: RM
authors.lastname: Cooper-Dehoff
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D035843:Biomedical Research / Q000639:trends*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents